These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 6432556
1. Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites. Del Maschio A, Livio M, Cerletti C, De Gaetano G. Eur J Pharmacol; 1984 Jun 01; 101(3-4):209-14. PubMed ID: 6432556 [Abstract] [Full Text] [Related]
3. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619. Hatmi M, del Maschio A, Lefort J, de gaetano G, Vargaftig BB, Cerletti C. J Pharmacol Exp Ther; 1987 May 01; 241(2):623-7. PubMed ID: 3106620 [Abstract] [Full Text] [Related]
4. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity. Cerletti C. Int J Tissue React; 1985 May 01; 7(4):309-12. PubMed ID: 3934097 [Abstract] [Full Text] [Related]
11. Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo. Lewis GP, Smith JR. Prostaglandins; 1984 Jul 01; 28(1):29-41. PubMed ID: 6435186 [Abstract] [Full Text] [Related]
12. Mechanisms of action of sulphinpyrazone. Wallis RB. Thromb Res Suppl; 1983 Jul 01; 4():31-8. PubMed ID: 6415857 [Abstract] [Full Text] [Related]
14. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Calzada C, Vericel E, Lagarde M. Biochem J; 1997 Jul 15; 325 ( Pt 2)(Pt 2):495-500. PubMed ID: 9230133 [Abstract] [Full Text] [Related]
15. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. Panara MR, Greco A, Santini G, Sciulli MG, Rotondo MT, Padovano R, di Giamberardino M, Cipollone F, Cuccurullo F, Patrono C. Br J Pharmacol; 1995 Nov 15; 116(5):2429-34. PubMed ID: 8581280 [Abstract] [Full Text] [Related]
17. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo. Pay GF, Wallis RB, Zelaschi D. Haemostasis; 1981 Nov 15; 10(3):165-75. PubMed ID: 7262645 [Abstract] [Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from "in vivo" drug interaction studies in rats. Cerletti C, Livio M, De Gaetano G. Biochim Biophys Acta; 1982 Jan 12; 714(1):122-8. PubMed ID: 6799004 [Abstract] [Full Text] [Related]
19. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. Carmo LG, Hatmi M, Rotilio D, Vargaftig BB. Br J Pharmacol; 1985 Aug 12; 85(4):849-59. PubMed ID: 2994786 [Abstract] [Full Text] [Related]